Taiwan FDA registration bdae884249ebfc7c296ad1da728f0918
Icekinxinhao blood glucose monitoring system
TW: 愛思金鑫豪血糖監測系統
Taiwan·Risk Class 2·Jinhong Medical Materials Technology Co., Ltd. Taoyuan Factory·Registered May 23, 2022 – May 23, 2027ActiveRegistration details
- Analysis ID
- bdae884249ebfc7c296ad1da728f0918
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Ace Medical Technology Co., Ltd.
Product details
- Intended Use
- It is used to measure the blood glucose concentration in human fresh fingertip microvascular whole blood and venous whole blood in vitro, which can be used by professionals to conduct blood glucose testing and self-blood glucose detection of diabetic patients.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- 國產;; QMS/QSD
Dates and status
- Registration Date
- May 23, 2022
- Expiry Date
- May 23, 2027
About this record
Access comprehensive regulatory information for Icekinxinhao blood glucose monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number bdae884249ebfc7c296ad1da728f0918 and manufactured by Jinhong Medical Materials Technology Co., Ltd. Taoyuan Factory. The authorized representative in Taiwan is Ace Medical Technology Co., Ltd..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices